Coya Therapeutics held its 2026 Annual Meeting of Stockholders on June 25, 2026. Stockholders elected Secretary Wilbur Ross and Dieter Weinand as Class I directors for three-year terms. The appointment of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for fiscal year 2026 was ratified.